FDA clears AngioDynamics' AlphaVac to treat pulmonary embolism

AngioDynamics this week announced it received FDA 510(k) clearance for its AlphaVac F18 system to treat pulmonary embolism (PE).

Related Keywords

,William Brent Keeling ,John Moriarty ,Juan Carlos Serna ,Emory University School Of Medicine ,Pulmonary Embolism Response Team ,Carlos Serna ,Acute Pulmonary Embolism Extraction Trial ,Alphavac System ,Emory University School ,